César Fuquen Leal Latin News Agency for Medicine and Public Health
As the medical literature has evidenced in recent months, he COVID-19 It could generate serious repercussions to the cardiovascular system of patients who get the virus.
The population that ends up hospitalized in intensive care units because of the new coronavirus would have an increased risk of multiple diseases such as heart attacks, clots and damage to the arterial system. This was evidenced by Dr. Héctor Martínez, cardiologist and president of the American College of Cardiology Capítulo de Puerto Rico in dialogue with the Journal of Medicine and Public Health (MSP).
“These manifestations of clots that can occur in the arterial or venous system and can also manifest as simulating myocardial infarction. This is nothing new. We have also seen it in other conditions associated with what is known as the famous multi-organ failure syndrome. It is when basically our system says: ‘enough is enough’ and begins to have an excessive dysregulation in terms of the part of coagulation versus the part of bleeding at all times”Cardiologist Martínez explained.
Are COVID patients at increased risk of clots?
“Another manifestation when a patient is critically ill is the clot and they cause heart attacks in the different important organs: infarcts in the brain, infarcts in the kidney, infarcts in the vessel, infarction even in the liver We have seen. They are manifestations of very critical acute conditions ”, warned the doctor.
When the patient is hospitalized and spends long hours lying down, experience with patients with COVID-19 has shown that the risk of blood clots is dramatically increased, which could trigger pulmonary embolisms, heart attacks and strokes.
“When we go to a balance of excess bleeding is when bleeding problems occur, which we have also seen because it has been documented that these patients with coronavirus can develop clots with greater propensity. Doctors have to be more aggressive in terms of the anticoagulation that is provided to these hospitalized patients. It is important to know that to this day the recommendation of the American Heart Academy and the American College of Cardiology is that these patients should be treated with heparin or with a low molecular weight heparin and none of the other novel anticoagulants as we know them are indicated. Perhaps in the future this could be an option, but at the moment only two are being used more for the coagulation prevention part of an anticoagulant event when a patient is hospitalized for a long time, such as these coronavirus patients, “he emphatically warned. Dr. Martínez.